CIBH
CIBH is a Belgian non-profit association founded in 1969 that convenes 47 pharmaceutical companies and 46 service providers through membership subscriptions, annual conferences, benchmarking tools (Santestat, CMF Database, Polaris Barometer), and a Benelux-wide healthcare data and analytics subsidiary (GERS Data Benelux) operated jointly with Cegedim.
- Company typePrivate
- Founded1969
- HeadquartersGlabais, Belgium
- Headcount11–50
- GTM typeB2B
- OfferingServices
What CIBH does
CIBH (Community of Intersectoral Belgian Healthcare) is a Belgian non-profit association (asbl-vzw) founded in 1969 in Glabais, Belgium, operating a membership-based platform that connects pharmaceutical industry decision-makers with healthcare service providers across the Benelux. The organization currently convenes 47 pharmaceutical companies as effective members and 46 service-provider companies as associate members, governed by a volunteer board of senior pharma executives. Its mission is to build bridges between industry decision-makers and service providers through knowledge exchange, networking, and collaborative initiatives anchored in the Belgian healthcare ecosystem.
CIBH's product portfolio spans four core offerings: Santestat, a free benchmarking tool providing pharmacies with peer performance comparison, price observatory, and sales analytics; GERS Data Benelux, a jointly controlled subsidiary with Cegedim delivering Benelux-wide healthcare market data, market-share analytics, and consulting services such as category analysis, cohort tracking, and visit/price elasticity studies; the CMF Database, a stakeholder directory connecting pharmaceutical market participants; and the Polaris Barometer, an annual consumer survey instrumenting attitudes toward the pharmaceutical market. The organization also runs a recurring conference and event program (e.g., 'Strategy Under Pressure' 15/10/2026, Trends in Pharmacy 2025) targeted at healthcare professionals.
Revenue is generated through three streams: annual membership subscriptions (effective and associate tiers, pricing undisclosed publicly), event participation fees that are free for members but range €190–€450 for non-members, and consulting/analytics revenue from the GERS Data Benelux subsidiary operated with partner Cegedim. CIBH employs 15 people, operates on a horizontal segmentation across two business-unit customer segments (pharma manufacturers and pharma service providers), and markets primarily through its member network, multilingual website (EN/FR/NL), and direct member communications rather than commercial promotion. No funding rounds, M&A, or parent-company ownership are disclosed; financials are not publicly reported.
CIBH firmographics
Firmographics- Name
- CIBH
- Legal name
- CIBH asbl-vzw
- Website
- https://cibh.be
- Company type
- Private
- Founded year
- 1969
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CIBH is a Belgian non-profit association founded in 1969 that convenes 47 pharmaceutical companies and 46 service providers through membership subscriptions, annual conferences, benchmarking tools (Santestat, CMF Database, Polaris Barometer), and a Benelux-wide healthcare data and analytics subsidiary (GERS Data Benelux) operated jointly with Cegedim.
- Ownership category
- akta.pro rank
Where CIBH is headquartered
LocationHeadquarters
- HQ city
- Glabais
- HQ country
- Belgium
- HQ region
- Europe
Offices1 record
Markets served
CIBH business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Membership Fees: CIBH generates revenue through annual membership fees from pharmaceutical companies (effective members) and service provider companies (associate members). Full membership is open to pharmaceutical product manufacturers, importers, and distributors, as well as companies marketing healthcare products. Associate membership is available to wholesale distributors, media publishers for healthcare professionals, and service companies operating in the pharmaceutical sector.
- Event Fees: Revenue generated from conference and event participation fees. Non-members pay higher fees (€250 per event) while members attend free of charge. Premium events like Trends in Pharmacy 2025 charged €450 for non-members.
- GERS Data Consulting Services: GERS Data Benelux, a CIBH subsidiary jointly owned with Cegedim, provides consulting services to pharmaceutical companies including category analysis, cohort tracking, visit elasticity, price elasticity, and competitive analysis studies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Full/Effective Membership - For pharmaceutical companies |
| Subscription | Annual | Associate Membership - For service companies |
| Unit Pricing | Pay-as-you-go | Event Participation - Non-Member Rate |
| Unit Pricing | Pay-as-you-go | Event Participation - Member Rate |
| Freemium | Monthly | Santestat - Free Pharmacy Statistics Tool |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
CIBH product offering
Product offeringCore offering
CIBH is a Belgian non-profit professional association that serves as a neutral community platform bridging pharmaceutical industry decision-makers with healthcare service providers. Its core offerings include an annual membership program (effective and associate memberships), industry conferences and networking events, pharmacy benchmarking tools (Santestat), a stakeholder directory (CMF Database), an annual consumer health barometer (Polaris), and Benelux healthcare market data and consulting services delivered through the GERS Data Benelux joint subsidiary with Cegedim.
Product overview
CIBH (Community of Intersectoral Belgian Healthcare) is a non-profit organization that serves as a platform for the Belgian pharmaceutical and healthcare industry. The organization operates several interconnected products: Santestat provides free pharmacy statistics and benchmarking tools; GERS Data Benelux (a subsidiary with Cegedim) delivers market data and consulting analytics; the CMF Database connects pharmaceutical stakeholders; and the Polaris Barometer conducts annual consumer surveys on health topics. Together with its conference and event program, these offerings create an integrated ecosystem for pharmaceutical market intelligence, professional development, and cross-sector collaboration in Belgian healthcare.
Differentiator
Problem solved
Functional benefit
Brands
- Santestat: Free statistics tool for pharmacies enabling performance comparison with similar colleagues, price benchmarking, and pharmacy management analytics.
- GERS Data Benelux
- CMF Database
- Polaris Barometer
Quantifiable outcome
- 47 pharmaceutical companies and 46 service providers participate as members
- +1 more outcomes
Companies that use CIBH
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
CIBH technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
CIBH partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- CegedimcoreGERS Data Benelux is a joint subsidiary of CIBH and Cegedim. Cegedim is a healthcare data company and together they provide data and analytics services for the Benelux healthcare market. This partnership leverages CIBH's healthcare industry connections and Cegedim's data infrastructure to deliver market intelligence, consulting services, and industry studies.
Scale indicators3 records
Recent moves6 records
Expansion highlights4 records
CIBH competitors and assessment
Company assessmentBroad incumbents
- IQVIA: Global leader in pharma and healthcare data, analytics, and market intelligence. Comparable as the dominant commercial provider of the kind of market-share, sales, and prescription data that CIBH's GERS Data Benelux also offers, but at global scale with a vastly larger product portfolio.
- IFPMA (International Federation of Pharmaceutical Manufacturers and Associations): Global pharma industry association. Similar trade-body function for pharma manufacturers, but at worldwide scale and focused on global health policy rather than the community/events/data model CIBH runs locally.
- EFPIA (European Federation of Pharmaceutical Industries and Associations): The pan-European pharma industry association. Comparable as a much larger industry body operating across the same pharma manufacturer constituency as CIBH, but at European rather than Belgian level and with a primarily policy/regulatory remit.
Direct peers
- BACHI (Belgian Association of the Consumer Healthcare Industry): Belgian trade association for consumer healthcare (OTC and self-care) companies. Comparable to CIBH as a Belgian pharma-adjacent industry body serving manufacturers with networking, data, and advocacy services.
- Medaxes: Belgian association for generic and biosimilar medicines manufacturers. Highly comparable as another Belgium-based pharma industry body representing manufacturers, distributors, and service providers in similar member-driven fashion.
- Pharma.be: The principal Belgian pharmaceutical industry federation representing innovative pharma companies. Directly comparable to CIBH as a Belgium-based pharma industry association, though with a more public-policy and lobbying focus rather than CIBH's community/events/data orientation.
Regional players
- vfa (Verband forschender Arzneimittelhersteller): German research-based pharma industry association. Comparable as a major European pharma trade body, but focused on Germany and tilted toward R&D-intensive manufacturers.
- LEEM (Les Entreprises du Médicament): French pharma industry association representing drug companies operating in France. Comparable trade-body model for pharma manufacturers in a neighboring European market, but with national-French rather than Belgian focus.
- Nefarma: Dutch pharma industry association (now part of HollandBIO/association landscape). Comparable as a Benelux pharma trade body, but serving the Netherlands market specifically rather than Belgium.
Others
- Cegedim: Healthcare technology and data company that is CIBH's JV partner in GERS Data Benelux. Comparable as a provider of healthcare market data and analytics services that overlap with the GERS Data Benelux offering, though operating as a commercial business rather than a trade association.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
CIBH social profiles
Digital presenceCIBH financial estimates
Financial estimateRevenue estimate
Valuation estimate
CIBH leadership team
Management profileNumber of profiles
Profiles1 record
CIBH subsidiaries and ownership
Company hierarchySubsidiaries1 record
CIBH funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CIBH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CIBH
What does CIBH do?
CIBH is a Belgian non-profit professional association that serves as a neutral community platform bridging pharmaceutical industry decision-makers with healthcare service providers. Its core offerings include an annual membership program (effective and associate memberships), industry conferences and networking events, pharmacy benchmarking tools (Santestat), a stakeholder directory (CMF Database), an annual consumer health barometer (Polaris), and Benelux healthcare market data and consulting services delivered through the GERS Data Benelux joint subsidiary with Cegedim.
Is CIBH a public or private company?
CIBH is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was CIBH founded?
CIBH was founded in 1969. It employs 11 to 50 people.
Where is CIBH based?
CIBH is headquartered in Glabais, Belgium, in the Europe region.
How does CIBH make money?
Three revenue lines are on record. Membership Fees are the primary driver. The others are event Fees and GERS Data Consulting Services.
Who are CIBH's main competitors?
Broad incumbents on record are IQVIA, IFPMA (International Federation of Pharmaceutical Manufacturers and Associations) and EFPIA (European Federation of Pharmaceutical Industries and Associations). Direct peers are BACHI (Belgian Association of the Consumer Healthcare Industry), Medaxes and Pharma.be. Regional players are vfa (Verband forschender Arzneimittelhersteller), LEEM (Les Entreprises du Médicament) and Nefarma. Cegedim is listed as an others.
Does CIBH have an API?
No public API is recorded for CIBH.